Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novartis identifies new NSD2 inhibitors

March 11, 2021

Bristol Myers Squibb discloses new IRAK-4 inhibitors

March 11, 2021

PI3K inhibitor umbralisib shows clinical activity in patients with indolent non-Hodgkin's lymphoma

March 10, 2021

Artios Pharma describes new POLQ inhibitors

March 10, 2021

Wigen Biomedicine Technology divulges KRAS mutant inhibitors

March 10, 2021

Pirtobrutinib demonstrates safety and efficacy in multiple B-cell malignancies

March 10, 2021

Dovitinib demonstrates promising antitumor activity in preclinical model of osteosarcoma

March 10, 2021

New model for invasive lobular carcinoma points to LOXL1 as a therapeutic target

March 9, 2021

IL-17 receptor's "B team" may be pancreatic cancer target

March 9, 2021

Bayer and DKFZ patent AhR antagonists

March 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...